FDA Approval of MS Drug Puts Ampligen Back In Play
Deja Vu? “I just try and not think about it, because it gets me furious” multiple sclerosis patient The story sounds eerily similar. Citing questions regarding study quality and side effects, the FDA refuses to approve a drug for a condition for which few...
The Chronic Fatigue Syndrome Community Spoke…and the FDA Listened: The FDA’s Evocative “Voice of the Patient’ Document
“CFS and ME is a serious disease or set of diseases for which there are currently no FDA approved therapies” ‘Voice of the Patient’ Document The FDA’s Patient Focused Drug Development Initiative marks the first time the FDA is implicitly including...FDA Puts the Squeeze on Pain Drugs – Some Fibromyalgia and Chronic Fatigue Syndrome Patients To See Effects
The F.D.A. recommendation is likely to have a significant impact on the availability of the drugs. New York Times Last week FDA’s ruling reclassifying narcotic pain relievers such as Vicodin and Lortab which contain hydrocodone combined with acetaminophen as...ME/CFS Patients Call To Action: Advocates Call for FDA to Hold ‘Real’ FDA Stakeholder’s Meeting
ATTENTION ME/CFS COMMUNITY We the “FDA Team” are asking you to send the message below to the FDA and to listed members of Congress. The recent patient-focused drug development meeting held by the FDA was a start – but only a start. The FDA stated...Lives Interrupted Latest Story
Allyn Archer
Atlanta, United States
Former occupation: Architect, Professor of Architecture
$2,768,291
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
